Clinical Trial Update: Hydroxyurea Therapy: Optimizing Access in Pediatric Populations Everywhere [Phase 2]

View source ↗

Summary

Phase 2 trial update on hydroxyurea therapy aimed at optimizing access in pediatric patients; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Thalassemia

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Sickle Cell Disease, Thalassemia | Phase 2 | Status: TERMINATED | Results posted: 2022-03-18